• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于神经炎症成像的靶向集落刺激因子 1 受体的 F-标记的邻氨基吡啶基炔基放射性配体。

F-Labeled o‑aminopyridyl alkynyl radioligands targeting colony-stimulating factor 1 receptor for neuroinflammation imaging.

机构信息

Key Laboratory of Radiopharmaceuticals (Beijing Normal University), Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, China.

Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.

出版信息

Bioorg Med Chem. 2023 Apr 1;83:117233. doi: 10.1016/j.bmc.2023.117233. Epub 2023 Mar 8.

DOI:10.1016/j.bmc.2023.117233
PMID:36933438
Abstract

We report the design, synthesis and evaluation of five o‑aminopyridyl alkynyl derivatives as colony-stimulating factor 1 receptor (CSF-1R) ligands. Compounds 4 and 5 with the fluoroethoxy group at the meta- or para-position of the phenyl ring possessed nanomolar inhibitory potency against CSF-1R with IC values of 7.6 nM and 2.3 nM, respectively. Radioligands [F]4 and [F]5 were obtained in radiochemical yields of 17.2 ± 5.3% (n = 5, decay-corrected) and 14.0 ± 4.3% (n = 4, decay-corrected), with radiochemical purity of > 99% and molar activity of 9-12 GBq/μmol (n = 5) and 6-8 GBq/μmol (n = 4), respectively. In biodistribution studies, radioligands [F]4 and [F]5 showed moderate brain uptake in male ICR mice with 1.52 ± 0.15 and 0.91 ± 0.07% ID/g, respectively, at 15 min. Metabolic stability studies in mouse brain revealed that [F]4 exhibited high stability while [F]5 suffered from low stability. Higher accumulation of [F]4 in the brain of lipopolysaccharide (LPS)-treated mice was observed, and further pretreatment of BLZ945 or CPPC led to remarkable reduction, indicating specific binding of [F]4 to CSF-1R.

摘要

我们报告了五个邻氨基吡啶基炔基衍生物作为集落刺激因子 1 受体(CSF-1R)配体的设计、合成和评价。在苯环的间位或对位带有氟乙氧基的化合物 4 和 5 对 CSF-1R 具有纳摩尔抑制活性,IC 值分别为 7.6 nM 和 2.3 nM。放射性配体 [F]4 和 [F]5 的放射化学产率分别为 17.2±5.3%(n=5,衰变校正)和 14.0±4.3%(n=4,衰变校正),放射化学纯度>99%,摩尔活度分别为 9-12 GBq/μmol(n=5)和 6-8 GBq/μmol(n=4)。在雄性 ICR 小鼠的生物分布研究中,放射性配体 [F]4 和 [F]5 在 15 分钟时分别显示出 1.52±0.15%和 0.91±0.07%ID/g 的中等脑摄取。在小鼠脑的代谢稳定性研究中,[F]4 表现出高稳定性,而 [F]5 则稳定性较低。在脂多糖(LPS)处理的小鼠的大脑中观察到 [F]4 的积累增加,并且进一步的 BLZ945 或 CPPC 预处理导致显著减少,表明 [F]4 与 CSF-1R 的特异性结合。

相似文献

1
F-Labeled o‑aminopyridyl alkynyl radioligands targeting colony-stimulating factor 1 receptor for neuroinflammation imaging.用于神经炎症成像的靶向集落刺激因子 1 受体的 F-标记的邻氨基吡啶基炔基放射性配体。
Bioorg Med Chem. 2023 Apr 1;83:117233. doi: 10.1016/j.bmc.2023.117233. Epub 2023 Mar 8.
2
BLZ945 derivatives for PET imaging of colony stimulating factor-1 receptors in the brain.BLZ945 衍生物用于脑内集落刺激因子-1 受体的 PET 成像。
Nucl Med Biol. 2021 Sep-Oct;100-101:44-51. doi: 10.1016/j.nucmedbio.2021.06.005. Epub 2021 Jun 23.
3
F-Labeled benzylpiperazine derivatives as highly selective ligands for imaging σ receptor with positron emission tomography.用正电子发射断层扫描成像σ受体的高选择性配体——F标记的苄基哌嗪衍生物
J Labelled Comp Radiopharm. 2019 Jun 30;62(8):425-437. doi: 10.1002/jlcr.3738.
4
Short-Term Colony-Stimulating Factor 1 Receptor Inhibition-Induced Repopulation After Stroke Assessed by Longitudinal F-DPA-714 PET Imaging.通过纵向 F-DPA-714 PET 成像评估中风后短期集落刺激因子 1 受体抑制诱导的再群体化。
J Nucl Med. 2022 Sep;63(9):1408-1414. doi: 10.2967/jnumed.121.263004. Epub 2022 Feb 3.
5
Synthesis and Preclinical Evaluation of Fluorinated 5-Azaindoles as CB2 PET Radioligands.氟代 5-氮杂吲哚的合成及 CB2 PET 放射性配体的临床前评价。
ACS Chem Neurosci. 2023 Aug 16;14(16):2902-2921. doi: 10.1021/acschemneuro.3c00345. Epub 2023 Jul 27.
6
PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R).通过靶向巨噬细胞集落刺激因子 1 受体 (CSF1R) 进行小胶质细胞的 PET 成像。
Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1686-1691. doi: 10.1073/pnas.1812155116. Epub 2019 Jan 11.
7
Synthesis and evaluation of new 1-oxa-8-azaspiro[4.5]decane derivatives as candidate radioligands for sigma-1 receptors.新型 1-氧杂-8-氮杂螺[4.5]癸烷衍生物的合成与评价作为 sigma-1 受体的候选放射性配体。
Bioorg Med Chem. 2020 Jul 15;28(14):115560. doi: 10.1016/j.bmc.2020.115560. Epub 2020 May 23.
8
Evaluation of a Positron Emission Tomography Tracer Targeting Colony-Stimulating Factor 1 Receptor for Detecting Pulmonary Inflammation.评估正电子发射断层扫描示踪剂靶向集落刺激因子 1 受体检测肺部炎症。
Mol Pharm. 2024 Aug 5;21(8):3979-3991. doi: 10.1021/acs.molpharmaceut.4c00337. Epub 2024 Jun 27.
9
Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.高亲和力和代谢稳定的 18F 标记的蛙皮素类似物的合成及放射药理学评价用于胃泌素释放肽受体表达的前列腺癌的分子成像。
Nucl Med Biol. 2013 Nov;40(8):1025-34. doi: 10.1016/j.nucmedbio.2013.07.005. Epub 2013 Aug 19.
10
Synthesis and pre-clinical evaluation of a new class of high-affinity F-labeled PSMA ligands for detection of prostate cancer by PET imaging.一类用于正电子发射断层扫描(PET)成像检测前列腺癌的新型高亲和力F标记前列腺特异性膜抗原(PSMA)配体的合成及临床前评估。
Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):647-661. doi: 10.1007/s00259-016-3556-5. Epub 2016 Nov 15.

引用本文的文献

1
Evaluation of in vivo and in vitro binding property of a novel candidate PET tracer for CSF1R imaging and comparison with two currently-used CSF1R-PET tracers.一种新型CSF1R成像候选PET示踪剂的体内和体外结合特性评估以及与两种目前使用的CSF1R-PET示踪剂的比较。
EJNMMI Radiopharm Chem. 2025 May 13;10(1):23. doi: 10.1186/s41181-025-00345-8.
2
Evaluation of in-vivo and in-vitro binding property of a novel PET tracer for CSF1R imaging and comparison with two currently-used CSF1R-PET tracers.一种用于CSF1R成像的新型PET示踪剂的体内和体外结合特性评估及其与两种目前使用的CSF1R-PET示踪剂的比较。
Res Sq. 2025 Mar 20:rs.3.rs-6194254. doi: 10.21203/rs.3.rs-6194254/v1.
3
Candidate Tracers for Imaging Colony-Stimulating Factor 1 Receptor in Neuroinflammation with Positron Emission Tomography: Issues and Progress.
用于正电子发射断层扫描成像神经炎症中集落刺激因子1受体的候选示踪剂:问题与进展
ACS Pharmacol Transl Sci. 2023 Oct 18;6(11):1632-1650. doi: 10.1021/acsptsci.3c00213. eCollection 2023 Nov 10.